Showing results (221-230 of 829) with videos related to

Sort By:
Pageof 83
The American Journal of Medicine|January 3, 2022
Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021Peter Rossing, Murray Epstein
Lancet (London, England)|October 1, 2008
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAnne Katrin Sjølie, Ronald Klein, Massimo Porta, et al.
Journal of Hypertension|October 8, 2009
Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuriaMatthew R Weir, Norman K Hollenberg, Dion H Zappe, et al.
Annals of Internal Medicine|May 20, 2009
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trialsRudy Bilous, Nish Chaturvedi, Anne Katrin Sjølie, et al.
Clinical Chemistry|October 16, 2010
Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitusSøren S Lund, Martin Petersen, Merete Frandsen, et al.
Diabetes, Obesity & Metabolism|April 1, 2018
Determining the optimal dose of atrasentan by evaluating the exposure-response relationships of albuminuria and bodyweightJeroen V Koomen, Jasper Stevens, Nael M Mostafa, et al.
Proteomics|August 15, 2013
Improving peptide relative quantification in MALDI-TOF MS for biomarker assessmentAmaya Albalat, Angelique Stalmach, Vasiliki Bitsika, et al.
Pageof 83